CA2385745C
(en)
|
2001-06-08 |
2015-02-17 |
Abbott Laboratories (Bermuda) Ltd. |
Methods of administering anti-tnf.alpha. antibodies
|
SI1425389T1
(sl)
|
2001-08-23 |
2012-02-29 |
Genmab As |
Humana protitelesa, specifična za interlevkin 15 (IL-15)
|
US7247304B2
(en)
|
2001-08-23 |
2007-07-24 |
Genmab A/S |
Methods of treating using anti-IL-15 antibodies
|
US7329405B2
(en)
|
2001-08-23 |
2008-02-12 |
Genmab A/S |
Human antibodies specific for interleukin 15 (IL-15)
|
GB0208817D0
(en)
*
|
2002-04-17 |
2002-05-29 |
European Molecular Biology Lab Embl |
Method for producing monoclonal antibodies
|
RS20050724A
(xx)
*
|
2003-02-26 |
2007-11-15 |
Genmab A/S., |
Humana antitela specifična za interleukin 15(il-15)
|
NZ570709A
(en)
|
2003-06-13 |
2010-04-30 |
Univ Pennsylvania |
Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same
|
US20050123542A1
(en)
*
|
2003-11-06 |
2005-06-09 |
Genmab A/S |
Methods for treating disorders involving monocytes
|
NZ554520A
(en)
*
|
2004-10-22 |
2010-03-26 |
Amgen Inc |
Methods for refolding of recombinant antibodies
|
MX2007006832A
(es)
*
|
2004-12-13 |
2007-08-07 |
Cytos Biotechnology Ag |
Arreglos de antigeno interleucina 15 y usos de los mismos.
|
KR101465456B1
(ko)
|
2005-05-16 |
2014-11-27 |
애브비 바이오테크놀로지 리미티드 |
미란성 다발관절염의 치료를 위한 tnf 억제제의 용도
|
WO2006138181A2
(en)
|
2005-06-14 |
2006-12-28 |
Amgen Inc. |
Self-buffering protein formulations
|
US20070190057A1
(en)
*
|
2006-01-23 |
2007-08-16 |
Jian Wu |
Methods for modulating mannose content of recombinant proteins
|
US9605064B2
(en)
|
2006-04-10 |
2017-03-28 |
Abbvie Biotechnology Ltd |
Methods and compositions for treatment of skin disorders
|
EP2010214A4
(en)
*
|
2006-04-10 |
2010-06-16 |
Abbott Biotech Ltd |
USES AND COMPOSITIONS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
|
US20080131374A1
(en)
*
|
2006-04-19 |
2008-06-05 |
Medich John R |
Uses and compositions for treatment of rheumatoid arthritis
|
AR065271A1
(es)
|
2007-02-09 |
2009-05-27 |
Genentech Inc |
Anticuerpos anti-robo4 y sus usos
|
EP2171451A4
(en)
|
2007-06-11 |
2011-12-07 |
Abbott Biotech Ltd |
METHOD FOR TREATING JUVENILIAN IDIOPATHIC ARTHRITIS
|
WO2009029795A1
(en)
*
|
2007-08-31 |
2009-03-05 |
Amgen Inc. |
Solid-state protein formulation
|
EP2197911A2
(en)
*
|
2007-09-14 |
2010-06-23 |
Amgen Inc. |
Homogeneous antibody populations
|
EP2205280B1
(en)
|
2007-09-27 |
2019-09-04 |
Amgen Inc. |
Pharmaceutical formulations
|
US8796206B2
(en)
|
2007-11-15 |
2014-08-05 |
Amgen Inc. |
Aqueous formulation of erythropoiesis stimulating protein stabilised by antioxidants for parenteral administration
|
TWI468417B
(zh)
|
2007-11-30 |
2015-01-11 |
Genentech Inc |
抗-vegf抗體
|
EP2098536A1
(en)
|
2008-03-05 |
2009-09-09 |
4-Antibody AG |
Isolation and identification of antigen- or ligand-specific binding proteins
|
JP2011517672A
(ja)
*
|
2008-03-24 |
2011-06-16 |
アボツト・バイオテクノロジー・リミテツド |
骨損失を治療するための方法及び組成物
|
CU23716A1
(es)
|
2008-09-30 |
2011-10-05 |
Ct Ingenieria Genetica Biotech |
Péptido antagonista de la actividad de la interleucina-15
|
UA109633C2
(uk)
|
2008-12-09 |
2015-09-25 |
|
Антитіло людини проти тканинного фактора
|
TW201106972A
(en)
|
2009-07-27 |
2011-03-01 |
Genentech Inc |
Combination treatments
|
US9321823B2
(en)
|
2009-09-02 |
2016-04-26 |
Genentech, Inc. |
Mutant smoothened and methods of using the same
|
MX344382B
(es)
|
2009-10-23 |
2016-12-14 |
Amgen Inc * |
Adaptador de vial y sistema.
|
US8486397B2
(en)
|
2009-12-11 |
2013-07-16 |
Genentech, Inc. |
Anti-VEGF-C antibodies and methods using same
|
MX361668B
(es)
|
2009-12-21 |
2018-12-11 |
Genentech Inc |
Formulación de anticuerpos.
|
DK2575935T4
(da)
|
2010-06-07 |
2023-11-27 |
Amgen Inc |
Anordning til indgivelse af lægemiddel
|
RS59769B1
(sr)
|
2010-06-09 |
2020-02-28 |
Genmab As |
Antitela protiv humanog cd38
|
CN111012921A
(zh)
|
2010-06-15 |
2020-04-17 |
根马布股份公司 |
针对组织因子的人抗体药物缀合物
|
ES2588981T3
(es)
|
2010-10-05 |
2016-11-08 |
Genentech, Inc. |
Smoothened mutante y métodos de uso de la misma
|
CA2831100C
(en)
|
2011-03-31 |
2020-02-18 |
Mark Dominis Holt |
Vial adapter and system
|
CA3021845C
(en)
|
2011-04-20 |
2022-03-29 |
Amgen Inc. |
Autoinjector apparatus
|
CN102250243B
(zh)
*
|
2011-07-01 |
2013-08-28 |
华绍炳 |
抗白细胞介素-15抗体
|
CN103797028B
(zh)
*
|
2011-07-18 |
2017-08-25 |
Iba 股份有限公司 |
使靶细胞可逆染色的方法
|
US9987428B2
(en)
|
2011-10-14 |
2018-06-05 |
Amgen Inc. |
Injector and method of assembly
|
US20150290390A1
(en)
|
2012-11-21 |
2015-10-15 |
Amgen Inc. |
Drug delivery device
|
JP6360077B2
(ja)
*
|
2013-02-20 |
2018-07-18 |
イナート・ファルマ・ソシエテ・アノニムInnate Pharma Pharma S.A. |
末梢t細胞リンパ腫の処置における使用のためのkir3dl2に特異的に結合する化合物
|
MY185551A
(en)
|
2013-03-13 |
2021-05-19 |
Genentech Inc |
Antibody formulations
|
HUE049707T2
(hu)
|
2013-03-13 |
2020-11-30 |
Hoffmann La Roche |
Csökkent oxidációjú kiszerelések
|
US10653779B2
(en)
|
2013-03-13 |
2020-05-19 |
Genentech, Inc. |
Formulations with reduced oxidation
|
KR102237885B1
(ko)
|
2013-03-13 |
2021-04-07 |
제넨테크, 인크. |
감소된 산화를 갖는 제제
|
US20140314778A1
(en)
|
2013-03-13 |
2014-10-23 |
Genentech, Inc. |
Formulations with reduced oxidation
|
EP2968760B1
(en)
|
2013-03-15 |
2024-01-03 |
Amgen Inc. |
Drug cassette, autoinjector, and autoinjector system
|
BR112015021993A8
(pt)
|
2013-03-15 |
2019-12-03 |
Genentech Inc |
polipeptídeo, métodos para sua produção, métodos para cultivo de uma célula, composição farmacêutica, kit, e meio de cultura celular
|
EP3593839A1
(en)
|
2013-03-15 |
2020-01-15 |
Amgen Inc. |
Drug cassette
|
WO2014149357A1
(en)
|
2013-03-22 |
2014-09-25 |
Amgen Inc. |
Injector and method of assembly
|
AR097791A1
(es)
|
2013-09-27 |
2016-04-13 |
Genentech Inc |
Formulaciones de anticuerpos anti-pdl1
|
CA3168888A1
(en)
|
2013-10-24 |
2015-04-30 |
Amgen Inc. |
Drug delivery system with temperature-sensitive control
|
EP3789064A1
(en)
|
2013-10-24 |
2021-03-10 |
Amgen, Inc |
Injector and method of assembly
|
AU2014364601A1
(en)
|
2013-12-17 |
2016-07-07 |
Genentech, Inc. |
Methods of treating HER2-positive cancers using PD-1 axis binding antagonists and anti-HER2 antibodies
|
BR112016013741A2
(pt)
|
2013-12-17 |
2017-10-03 |
Genentech Inc |
Usos de antagonistas de ligação de eixo de pd-1 e um anticorpo de anti-cd20, e kit compreendendo os mesmos
|
CA2934028A1
(en)
|
2013-12-17 |
2015-06-25 |
Genentech, Inc. |
Combination therapy comprising ox40 binding agonists and pd-1 axis binding antagonists
|
AU2015214264B2
(en)
|
2014-02-04 |
2018-12-20 |
Curis, Inc. |
Mutant Smoothened and methods of using the same
|
US10994112B2
(en)
|
2014-02-05 |
2021-05-04 |
Amgen Inc. |
Drug delivery system with electromagnetic field generator
|
RU2016142476A
(ru)
|
2014-03-31 |
2018-05-07 |
Дженентек, Инк. |
Комбинированная терапия, включающая антиангиогенезные агенты и агонисты, связывающие ох40
|
SG10201811702TA
(en)
|
2014-05-07 |
2019-01-30 |
Amgen Inc |
Autoinjector with shock reducing elements
|
CA2948003C
(en)
|
2014-06-03 |
2023-06-27 |
Amgen Inc. |
Drug delivery system and method of use
|
EP2963057A1
(en)
|
2014-07-02 |
2016-01-06 |
Calypso Biotech SA |
Antibodies to IL-15
|
AU2015318001B2
(en)
|
2014-09-15 |
2021-03-25 |
Genentech, Inc. |
Antibody formulations
|
WO2016061220A2
(en)
|
2014-10-14 |
2016-04-21 |
Amgen Inc. |
Drug injection device with visual and audio indicators
|
EA202191513A1
(ru)
|
2014-10-23 |
2021-11-30 |
Эмджен Инк. |
Снижение вязкости фармацевтических составов
|
BR112017010198A2
(pt)
|
2014-11-17 |
2017-12-26 |
Genentech Inc |
terapia de combinação compreendendo agonistas de ligação a ox40 e antagonistas de ligação ao eixo de pd-1
|
JP6716566B2
(ja)
|
2014-12-19 |
2020-07-01 |
アムジエン・インコーポレーテツド |
近接センサ付き薬物送達装置
|
EP3689394A1
(en)
|
2014-12-19 |
2020-08-05 |
Amgen Inc. |
Drug delivery device with live button or user interface field
|
EP3253784B1
(en)
|
2015-02-04 |
2020-05-06 |
Genentech, Inc. |
Mutant smoothened and methods of using the same
|
EP3258988B1
(en)
|
2015-02-17 |
2019-08-28 |
Amgen Inc. |
Drug delivery device with vacuum assisted securement and/or feedback
|
EP3981450A1
(en)
|
2015-02-27 |
2022-04-13 |
Amgen, Inc |
Drug delivery device having a needle guard mechanism with a tunable threshold of resistance to needle guard movement
|
WO2016205320A1
(en)
|
2015-06-17 |
2016-12-22 |
Genentech, Inc. |
Methods of treating locally advanced or metastatic breast cancers using pd-1 axis binding antagonists and taxanes
|
JOP20200312A1
(ar)
|
2015-06-26 |
2017-06-16 |
Novartis Ag |
الأجسام المضادة للعامل xi وطرق الاستخدام
|
TW202330904A
(zh)
|
2015-08-04 |
2023-08-01 |
美商再生元醫藥公司 |
補充牛磺酸之細胞培養基及用法
|
HRP20231544T1
(hr)
|
2015-08-13 |
2024-03-15 |
Amgen Inc. |
Nabijena dubinska filtracija proteina koji vežu antigene
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
ES2755717T3
(es)
|
2015-12-09 |
2020-04-23 |
Amgen Inc |
Autoinyector con tapa de señalización
|
WO2017117304A1
(en)
|
2015-12-30 |
2017-07-06 |
Genentech, Inc. |
Use of tryptophan derivatives for protein formulations
|
SG11201804961UA
(en)
|
2015-12-30 |
2018-07-30 |
Genentech Inc |
Formulations with reduced degradation of polysorbate
|
WO2017120178A1
(en)
|
2016-01-06 |
2017-07-13 |
Amgen Inc. |
Auto-injector with signaling electronics
|
US10596257B2
(en)
|
2016-01-08 |
2020-03-24 |
Hoffmann-La Roche Inc. |
Methods of treating CEA-positive cancers using PD-1 axis binding antagonists and anti-CEA/anti-CD3 bispecific antibodies
|
JP2019509721A
(ja)
|
2016-02-04 |
2019-04-11 |
キュリス,インコーポレイテッド |
突然変異体スムースンド及びその使用方法
|
DK3429663T3
(da)
|
2016-03-15 |
2020-09-28 |
Amgen Inc |
Reduktion af sandsynligheden for glasbrud i anordninger til indgivelse af lægemidler
|
CA3016552A1
(en)
|
2016-03-15 |
2017-09-21 |
Genentech, Inc. |
Methods of treating cancers using pd-1 axis binding antagonists and anti-gpc3 antibodies
|
WO2017189089A1
(en)
|
2016-04-29 |
2017-11-02 |
Amgen Inc. |
Drug delivery device with messaging label
|
US11389588B2
(en)
|
2016-05-02 |
2022-07-19 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
JP7309363B2
(ja)
|
2016-05-13 |
2023-07-18 |
アムジエン・インコーポレーテツド |
バイアル・スリーブ組立体
|
WO2017200989A1
(en)
|
2016-05-16 |
2017-11-23 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
TW201802121A
(zh)
|
2016-05-25 |
2018-01-16 |
諾華公司 |
抗因子XI/XIa抗體之逆轉結合劑及其用途
|
US11541176B2
(en)
|
2016-06-03 |
2023-01-03 |
Amgen Inc. |
Impact testing apparatuses and methods for drug delivery devices
|
US20180002417A1
(en)
*
|
2016-06-15 |
2018-01-04 |
Celimmune Llc |
Methods and Compositions for the Treatment of Celiac Disease, Non-Celiac Gluten Sensitivity, and Refractory Celiac Disease
|
EP3478342A1
(en)
|
2016-07-01 |
2019-05-08 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
CN109476748B
(zh)
|
2016-08-08 |
2023-05-23 |
豪夫迈·罗氏有限公司 |
用于癌症的治疗和诊断方法
|
US20190328965A1
(en)
|
2016-08-17 |
2019-10-31 |
Amgen Inc. |
Drug delivery device with placement detection
|
JP7275027B2
(ja)
|
2016-10-06 |
2023-05-17 |
アムジェン インコーポレイテッド |
粘度低下タンパク質医薬製剤
|
EP3528787A4
(en)
*
|
2016-10-21 |
2020-05-06 |
Amgen Inc. |
PHARMACEUTICAL FORMULATIONS AND PROCESSES FOR THEIR PREPARATION
|
US20200261643A1
(en)
|
2016-10-25 |
2020-08-20 |
Amgen Inc. |
On-body injector
|
UA126284C2
(uk)
*
|
2016-12-21 |
2022-09-14 |
Сефалон, Інк. |
Антитіла, які специфічно зв'язуються з людським il-15, та їхнє застосування
|
BR112019012667A2
(pt)
|
2016-12-23 |
2020-02-11 |
Novartis Ag |
Anticorpos do fator xi e métodos de uso
|
MX2019008432A
(es)
|
2017-01-17 |
2019-11-18 |
Amgen Inc |
Dispositivos de inyeccion y metodos relacionados de uso y ensamblaje.
|
CA3052204A1
(en)
|
2017-02-17 |
2018-08-23 |
Amgen Inc. |
Insertion mechanism for drug delivery device
|
AU2018220538B2
(en)
|
2017-02-17 |
2023-12-14 |
Amgen Inc. |
Drug delivery device with sterile fluid flowpath and related method of assembly
|
MX2019010544A
(es)
|
2017-03-06 |
2019-10-21 |
Amgen Inc |
Dispositivo de administracion de farmacos con caracteristica de prevencion de la activacion.
|
CA3052482A1
(en)
|
2017-03-07 |
2018-09-13 |
Amgen Inc. |
Needle insertion by overpressure
|
SG11201908062QA
(en)
|
2017-03-09 |
2019-09-27 |
Amgen Inc |
Insertion mechanism for drug delivery device
|
CN110446512B
(zh)
|
2017-03-28 |
2022-03-18 |
美国安进公司 |
柱塞杆和注射器组件系统以及方法
|
WO2018200556A1
(en)
|
2017-04-24 |
2018-11-01 |
University Of Massachusetts |
Diagnosis and treatment of vitiligo
|
AU2018258676A1
(en)
|
2017-04-28 |
2019-10-31 |
Amgen Inc. |
N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides
|
US11904143B2
(en)
|
2017-06-08 |
2024-02-20 |
Amgen Inc. |
Torque driven drug delivery device
|
WO2018226515A1
(en)
|
2017-06-08 |
2018-12-13 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
CA3063920A1
(en)
|
2017-06-22 |
2018-12-27 |
Amgen Inc. |
Device activation impact/shock reduction
|
EP3641861A1
(en)
|
2017-06-23 |
2020-04-29 |
Amgen Inc. |
Electronic drug delivery device comprising a cap activated by a switch assembly
|
JP7408398B2
(ja)
|
2017-07-14 |
2024-01-05 |
アムジエン・インコーポレーテツド |
二重ねじりばねシステムを有する針挿入後退システム
|
MA49626A
(fr)
|
2017-07-21 |
2020-05-27 |
Amgen Inc |
Élément d'étanchéité perméable aux gaz pour récipient à médicament et procédés d'assemblage
|
US11484648B2
(en)
|
2017-07-25 |
2022-11-01 |
Amgen Inc. |
Drug delivery device with container access system and related method of assembly
|
WO2019022951A1
(en)
|
2017-07-25 |
2019-01-31 |
Amgen Inc. |
DRUG DELIVERY DEVICE WITH GEAR MODULE AND ASSEMBLY METHOD THEREOF
|
CA3071636A1
(en)
|
2017-08-01 |
2019-02-07 |
Amgen Inc. |
Systems and methods for performing a real-time glycan assay of a sample
|
EP3662287B1
(en)
|
2017-08-01 |
2024-02-28 |
Amgen Inc. |
Systems and methods for real time preparation of a polypeptide sample for anaylsis with mass spectrometry
|
WO2019032482A2
(en)
|
2017-08-09 |
2019-02-14 |
Amgen Inc. |
HYDRAULIC-PNEUMATIC PRESSURE CHAMBER DELIVERY SYSTEM
|
MA49897A
(fr)
|
2017-08-18 |
2020-06-24 |
Amgen Inc |
Injecteur sur-corps avec patch adhésif stérile
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
WO2019070472A1
(en)
|
2017-10-04 |
2019-04-11 |
Amgen Inc. |
FLOW ADAPTER FOR MEDICATION DELIVERY DEVICE
|
US11813426B2
(en)
|
2017-10-06 |
2023-11-14 |
Amgen Inc. |
Drug delivery device including seal member for needle of syringe
|
WO2019074579A1
(en)
|
2017-10-09 |
2019-04-18 |
Amgen Inc. |
DRUG DELIVERY DEVICE COMPRISING A DRIVE ASSEMBLY AND ASSEMBLY METHOD THEREOF
|
MA50527A
(fr)
|
2017-11-03 |
2020-09-09 |
Amgen Inc |
Système et approches pour stériliser un dispositif d'administration de médicament
|
US20200338271A1
(en)
|
2017-11-06 |
2020-10-29 |
Amgen Inc. |
Fill-finish assemblies and related methods
|
JP2021501616A
(ja)
|
2017-11-06 |
2021-01-21 |
アムジエン・インコーポレーテツド |
配置及び流量検出を備える薬物送達デバイス
|
SG11202002966QA
(en)
|
2017-11-10 |
2020-05-28 |
Amgen Inc |
Plungers for drug delivery devices
|
MX2020004996A
(es)
|
2017-11-16 |
2020-08-27 |
Amgen Inc |
Un mecanismo de pestillo de puerta para un dispositivo de administracion de farmacos.
|
AU2018368338A1
(en)
|
2017-11-16 |
2020-04-09 |
Amgen Inc. |
Autoinjector with stall and end point detection
|
MA51617A
(fr)
|
2018-01-17 |
2020-11-25 |
Amgen Inc |
Mécanisme d'administration de médicament
|
WO2019173026A1
(en)
|
2018-03-07 |
2019-09-12 |
Amgen Inc. |
Controlled dispense syringe
|
WO2019173785A1
(en)
|
2018-03-09 |
2019-09-12 |
Amgen Inc. |
Backflow prevention mechanism for drug delivery device
|
JP2021516672A
(ja)
|
2018-03-13 |
2021-07-08 |
アムジエン・インコーポレーテツド |
質量分光測定分析のためのトリプシン耐性ポリペプチドを調製するための方法
|
WO2019178280A1
(en)
|
2018-03-13 |
2019-09-19 |
Amgen Inc. |
Sequential digestion of polypeptides for mass spectrometric analysis
|
PL3775857T3
(pl)
|
2018-03-30 |
2024-01-29 |
Amgen Inc. |
Sprawdzanie pojemnika na lek z wykorzystaniem kamery
|
US11583633B2
(en)
|
2018-04-03 |
2023-02-21 |
Amgen Inc. |
Systems and methods for delayed drug delivery
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
MX2020014091A
(es)
|
2018-06-23 |
2021-05-27 |
Genentech Inc |
Metodos para tratar el cancer de pulmon con un antagonista de fijacion al eje pd-1, un agente de platino y un inhibidor de la topoisomerasa ii.
|
TW202011991A
(zh)
|
2018-07-18 |
2020-04-01 |
美商建南德克公司 |
用pd-1軸結合拮抗劑、抗代謝劑及鉑劑治療肺癌之方法
|
MX2021000748A
(es)
|
2018-07-24 |
2021-03-26 |
Amgen Inc |
Dispositivos de suministro para administrar farmacos.
|
WO2020023451A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Delivery devices for administering drugs
|
WO2020023220A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with tacky skin attachment portion and related method of preparation
|
WO2020023336A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
US20210228797A1
(en)
|
2018-07-31 |
2021-07-29 |
Amgen Inc. |
Fluid path assembly for a drug delivery device
|
JP2021533149A
(ja)
|
2018-08-08 |
2021-12-02 |
ジェネンテック, インコーポレイテッド |
タンパク質製剤のためのトリプトファン誘導体及びl−メチオニンの使用
|
MA53227A
(fr)
|
2018-08-17 |
2021-11-24 |
Amgen Inc |
Mécanisme d'activation pour dispositif d'administration de médicament
|
MX2021003213A
(es)
|
2018-09-21 |
2021-05-12 |
Genentech Inc |
Metodos de diagnostico para cancer de mama triple negativo.
|
AU2019347710A1
(en)
|
2018-09-24 |
2021-02-04 |
Amgen Inc. |
Interventional dosing systems and methods
|
EP3856283A1
(en)
|
2018-09-28 |
2021-08-04 |
Amgen Inc. |
Muscle wire escapement activation assembly for a drug delivery device
|
CN112805048B
(zh)
|
2018-10-02 |
2023-09-22 |
安进公司 |
具有内部力传递的用于药物递送的注射系统
|
MA53818A
(fr)
|
2018-10-05 |
2022-01-12 |
Amgen Inc |
Dispositif d'administration de médicament ayant un indicateur de dose
|
CN117138169A
(zh)
|
2018-10-15 |
2023-12-01 |
安进公司 |
药物递送装置
|
WO2020081480A1
(en)
|
2018-10-15 |
2020-04-23 |
Amgen Inc. |
Platform assembly process for drug delivery device
|
US11213620B2
(en)
|
2018-11-01 |
2022-01-04 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
AU2019370159A1
(en)
|
2018-11-01 |
2021-04-22 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
US20220146413A1
(en)
|
2018-12-14 |
2022-05-12 |
Amgen Inc. |
System suitability method for use with protein concentration determination by slope
|
AU2020212547A1
(en)
|
2019-01-24 |
2021-06-10 |
Amgen Inc. |
Drug delivery systems and methods with back pressure sensing
|
US11534547B2
(en)
|
2019-01-24 |
2022-12-27 |
Amgen Inc. |
Drug delivery systems and methods with pressure sensitive control
|
US20220062543A1
(en)
|
2019-02-12 |
2022-03-03 |
Amgen Inc. |
Continuous dosing systems and approaches
|
US20200254173A1
(en)
|
2019-02-12 |
2020-08-13 |
Amgen Inc. |
Take-home drug delivery system
|
WO2020167910A1
(en)
|
2019-02-12 |
2020-08-20 |
Amgen Inc. |
Systems and approaches for drug delivery device reconstitution
|
JP2022519132A
(ja)
|
2019-02-12 |
2022-03-18 |
アムジエン・インコーポレーテツド |
投薬システム及び手法
|
US20220096747A1
(en)
|
2019-02-12 |
2022-03-31 |
Amgen Inc. |
Continuous dosing systems and approaches
|
AU2020221446A1
(en)
|
2019-02-12 |
2021-07-01 |
Amgen Inc. |
Continuous dosing systems and approaches
|
WO2020168156A1
(en)
|
2019-02-14 |
2020-08-20 |
Amgen Inc. |
Systems and methods for preparing a sample and performing a real-time assay of the sample
|
CA3127817A1
(en)
|
2019-02-20 |
2020-08-27 |
Amgen Inc. |
Methods of determining protein stability
|
EP3935396A1
(en)
|
2019-03-04 |
2022-01-12 |
Amgen Inc. |
In vivo reversibility of high molecular weight species
|
US20220187398A1
(en)
|
2019-03-27 |
2022-06-16 |
Amgen Inc. |
Methods of fingerprinting therapeutic proteins via a two-dimensional (2d) nuclear magnetic resonance technique at natural abundance for formulated biopharmaceutical products
|
EP3952950A1
(en)
|
2019-04-08 |
2022-02-16 |
Amgen Inc. |
Automated drug delivery device and container
|
EP3952956A1
(en)
|
2019-04-09 |
2022-02-16 |
Amgen Inc. |
Drug delivery device with smart grip
|
MX2021012476A
(es)
|
2019-04-17 |
2021-11-12 |
Amgen Inc |
Cartucho para un autoinyector y metodos relacionados.
|
US20220152304A1
(en)
|
2019-04-24 |
2022-05-19 |
Amgen Inc. |
Injector accessories
|
US20220160972A1
(en)
|
2019-04-24 |
2022-05-26 |
Amgen Inc. |
Syringe sterilization verification assemblies and methods
|
US20220260584A1
(en)
|
2019-06-05 |
2022-08-18 |
Amgen Inc. |
Methods of identifying attributes of therapeutic proteins
|
KR20220020879A
(ko)
|
2019-06-12 |
2022-02-21 |
에스크진 파마, 아이엔씨. |
새로운 il-15 프로드럭 및 이를 사용하는 방법
|
US20220347398A1
(en)
|
2019-06-20 |
2022-11-03 |
Amgen Inc. |
Wireless Communication Enabled Drug Delivery Device and Method
|
US20220249778A1
(en)
|
2019-07-18 |
2022-08-11 |
Amgen Inc. |
Sealing arrangement for drug delivery device
|
US20220362474A1
(en)
|
2019-07-18 |
2022-11-17 |
Amgen Inc. |
Drug delivery device having pressurized vessel
|
AU2020321951A1
(en)
|
2019-08-01 |
2022-02-17 |
Amgen Inc. |
Drug delivery device with temperature measurement and related method
|
MX2022002149A
(es)
|
2019-08-23 |
2022-03-17 |
Amgen Inc |
Dispositivo de suministro de farmacos con componentes de acoplamiento de capuchon de aguja configurable y metodos relacionados.
|
MX2022002580A
(es)
|
2019-09-03 |
2022-03-22 |
Amgen Inc |
Dispositivo de inyeccion activable para administracion de farmacos.
|
JP2022546082A
(ja)
|
2019-09-03 |
2022-11-02 |
アムジエン・インコーポレーテツド |
薬物送達のための注入デバイス及び注入デバイスのためのパッケージ
|
US20220362462A1
(en)
|
2019-09-12 |
2022-11-17 |
Amgen Inc. |
Backflow Prevention Mechanism for Drug Delivery Device
|
WO2021056020A1
(en)
|
2019-09-16 |
2021-03-25 |
Amgen Inc. |
Method for external sterilization of drug delivery device
|
AU2020357201A1
(en)
|
2019-09-30 |
2022-03-17 |
Amgen Inc. |
Drug delivery device
|
CA3155062A1
(en)
|
2019-09-30 |
2021-04-08 |
Amgen Inc. |
Drug delivery device
|
AU2020359435A1
(en)
|
2019-09-30 |
2022-03-24 |
Amgen Inc. |
Drug delivery device
|
CN114423475B
(zh)
|
2019-09-30 |
2024-03-26 |
美国安进公司 |
药物递送装置和用于递送药物的方法
|
US20210093796A1
(en)
|
2019-09-30 |
2021-04-01 |
Amgen Inc. |
Drug delivery device
|
CA3151476A1
(en)
|
2019-09-30 |
2021-04-08 |
Amgen Inc. |
Drug delivery device
|
EP4041649A1
(en)
|
2019-10-07 |
2022-08-17 |
Amgen Inc. |
Packages for pharmaceutical products and methods of assembly
|
US11660435B2
(en)
|
2019-10-07 |
2023-05-30 |
Amgen Inc. |
Light-activated ultrasonic delivery and manipulation of liquid medication from a drug reservoir
|
US20220355025A1
(en)
|
2019-10-07 |
2022-11-10 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
US20220362484A1
(en)
|
2019-10-07 |
2022-11-17 |
Amgen Inc. |
Drug delivery device
|
EP4041345A1
(en)
|
2019-10-08 |
2022-08-17 |
Amgen Inc. |
Drug delivery device
|
JP2022552184A
(ja)
|
2019-10-08 |
2022-12-15 |
アムジエン・インコーポレーテツド |
薬物送達デバイスの温度表示部
|
WO2021071740A1
(en)
|
2019-10-08 |
2021-04-15 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
JP2022552239A
(ja)
|
2019-10-08 |
2022-12-15 |
アムジエン・インコーポレーテツド |
オートインジェクタ用のカセット及び関連方法
|
EP4045109A1
(en)
|
2019-10-18 |
2022-08-24 |
Amgen Inc. |
Systems and approaches for drug delivery device reconstitution
|
EP4045110A2
(en)
|
2019-10-18 |
2022-08-24 |
Amgen Inc. |
Drug delivery device and system
|
CA3153762A1
(en)
|
2019-10-18 |
2021-04-22 |
Amgen Inc. |
Systems and approaches for drug delivery device reconstitution
|
WO2021076540A1
(en)
|
2019-10-18 |
2021-04-22 |
Amgen Inc. |
Drug delivery device and system
|
WO2021080828A1
(en)
|
2019-10-21 |
2021-04-29 |
Amgen Inc. |
Drug product container and drug delivery system
|
US20220387702A1
(en)
|
2019-10-24 |
2022-12-08 |
Amgen Inc. |
Drug delivery device
|
WO2021080822A1
(en)
|
2019-10-24 |
2021-04-29 |
Amgen Inc. |
Systems and methods for drug delivery
|
WO2021081321A1
(en)
|
2019-10-24 |
2021-04-29 |
Amgen Inc. |
Systems and approaches for drug delivery
|
WO2021081161A1
(en)
|
2019-10-24 |
2021-04-29 |
Amgen Inc. |
Systems and components for drug delivery and components for preparation of the same
|
WO2021081186A1
(en)
|
2019-10-24 |
2021-04-29 |
Amgen Inc. |
Drug delivery device and system
|
US20220395635A1
(en)
|
2019-11-07 |
2022-12-15 |
Amgen Inc. |
Drug delivery system and method of use
|
EP4069340A1
(en)
|
2019-12-02 |
2022-10-12 |
Amgen Inc. |
Lockout mechanism for drug delivery device
|
EP4069331A1
(en)
|
2019-12-05 |
2022-10-12 |
Amgen Inc. |
Flow restrictor for drug delivery device
|
AU2021205981A1
(en)
|
2020-01-11 |
2022-07-14 |
AskGene Pharma, Inc. |
Novel masked cytokines and methods of use thereof
|
WO2021146043A1
(en)
|
2020-01-13 |
2021-07-22 |
Amgen Inc. |
Needle shield removers, drug delivery devices, and related methods
|
EP4110427A1
(en)
|
2020-02-24 |
2023-01-04 |
Amgen Inc. |
Containers and systems for use during external sterilization of drug delivery devices
|
CN115243748A
(zh)
|
2020-03-16 |
2022-10-25 |
美国安进公司 |
药物递送构件插入感测组件、药物递送装置和相关方法
|
EP4121145A1
(en)
|
2020-03-17 |
2023-01-25 |
Amgen Inc. |
Controlled dispense syringe
|
EP4143811A1
(en)
|
2020-04-28 |
2023-03-08 |
Amgen Inc. |
Packaging label
|
CA3181425A1
(en)
|
2020-05-22 |
2021-11-25 |
Amgen Inc. |
Storage system and method for storing and transporting medicament
|
CN115916182A
(zh)
|
2020-06-16 |
2023-04-04 |
基因泰克公司 |
用于治疗三阴性乳腺癌的方法和组合物
|
CA3189330A1
(en)
|
2020-09-02 |
2022-03-10 |
Amgen Inc. |
Easy open apparatus for medicament storage carton
|
WO2022055779A1
(en)
|
2020-09-09 |
2022-03-17 |
Amgen Inc. |
Swallowable drug delivery devices
|
WO2022055761A1
(en)
|
2020-09-11 |
2022-03-17 |
Amgen Inc. |
Inline uv flow device for sterilizing flow cytometry sheath fluid
|
CA3195365A1
(en)
|
2020-09-18 |
2022-03-24 |
Amgen Inc. |
Methods of processing a sample for peptide mapping analysis
|
WO2022081276A1
(en)
|
2020-10-12 |
2022-04-21 |
Amgen Inc. |
Long-term medicament storage apparatus and methods
|
CA3196039A1
(en)
|
2020-11-04 |
2022-05-12 |
Amgen Inc. |
Drug delivery device assembly and accessory for drug delivery device
|
AU2021376245A1
(en)
|
2020-11-04 |
2023-04-13 |
Amgen Inc. |
Drug delivery device assembly and accessory for drug delivery device
|
US20230381423A1
(en)
|
2020-11-04 |
2023-11-30 |
Amgen Inc. |
Drug delivery device assembly and accessory for drug delivery device
|
EP4240448A1
(en)
|
2020-11-04 |
2023-09-13 |
Amgen Inc. |
Drug delivery device assembly and accessory for drug delivery device
|
CA3200262A1
(en)
|
2020-11-05 |
2022-05-12 |
Amgen Inc. |
Materials and methods for protein processing
|
US20240103025A1
(en)
|
2021-02-03 |
2024-03-28 |
Amgen Inc. |
Systems and approaches for drug processing
|
US20240115462A1
(en)
|
2021-02-03 |
2024-04-11 |
Amgen Inc. |
High-throughput automated reconstitution of lyophilized drug product
|
EP4288017A1
(en)
|
2021-02-03 |
2023-12-13 |
Amgen Inc. |
Coaxial needle adapter and guide bracket for robotic liquid handling platform
|
WO2022192100A1
(en)
|
2021-03-08 |
2022-09-15 |
Amgen Inc. |
Manufacturing process for hollow plunger rod
|
WO2022192310A1
(en)
|
2021-03-10 |
2022-09-15 |
Amgen Inc. |
Drug delivery device, subassembly for drug delivery device, syringe holder, and method of assembly
|
CA3211430A1
(en)
|
2021-03-10 |
2022-09-15 |
Amgen Inc. |
Drug delivery device having removable cap
|
CN116963795A
(zh)
|
2021-03-10 |
2023-10-27 |
美国安进公司 |
药物递送装置
|
JP2024510668A
(ja)
|
2021-03-25 |
2024-03-08 |
アムジエン・インコーポレーテツド |
薬物送達デバイス
|
CN117062640A
(zh)
|
2021-03-31 |
2023-11-14 |
美国安进公司 |
用于药物递送装置的基于声音检测的注射时间测量系统
|
EP4327056A1
(en)
|
2021-04-22 |
2024-02-28 |
Amgen Inc. |
Methods and systems for automated syringe quality evaluation
|
AU2022266655A1
(en)
|
2021-04-28 |
2023-09-21 |
Amgen Inc. |
Systems for out-patient treatment of a patient, and related methods
|
WO2022245574A1
(en)
|
2021-05-17 |
2022-11-24 |
Amgen Inc. |
Feedback system and method for a drug product
|
CN117320964A
(zh)
|
2021-05-21 |
2023-12-29 |
美国安进公司 |
优化药物容器的灌装方案的方法
|
EP4348141A1
(en)
|
2021-06-01 |
2024-04-10 |
Amgen Inc. |
Lyophilization system
|
WO2022260925A1
(en)
|
2021-06-08 |
2022-12-15 |
Amgen Inc. |
Drug delivery devices, finger-grip elements, and related methods
|
AR126167A1
(es)
|
2021-06-17 |
2023-09-27 |
Amgen Inc |
Dispositivo de suministro de fármacos que tiene un amortiguador
|
AU2022296519A1
(en)
|
2021-06-23 |
2024-01-18 |
Amgen Inc. |
Syringes, assemblies, and methods of manufacture
|
WO2023278125A1
(en)
|
2021-06-28 |
2023-01-05 |
Amgen Inc. |
Safety device for drug delivery system
|
WO2023287562A1
(en)
|
2021-07-16 |
2023-01-19 |
Amgen Inc. |
Systems and approaches for drug processing single-use hardware
|
CA3228140A1
(en)
|
2021-09-29 |
2023-04-06 |
Amgen Inc. |
Apparatuses, systems and methods for plunger-stopper depth measurement in pre-filled syringes
|
CA3230837A1
(en)
|
2021-10-06 |
2023-04-13 |
Amgen Inc. |
Impact activated brake feature for drug delivery device
|
CA3233406A1
(en)
|
2021-10-06 |
2023-04-13 |
Amgen Inc. |
Impact activated retention feature for drug delivery device
|
AU2022366707A1
(en)
|
2021-10-11 |
2024-03-14 |
Amgen Inc. |
Characterization apparatus for drug delivery devices or subcomponents thereof
|
CA3236206A1
(en)
|
2021-11-05 |
2023-05-11 |
Amgen Inc. |
Drug delivery devices, components for use within drug delivery devices
|
WO2023086793A1
(en)
|
2021-11-09 |
2023-05-19 |
Amgen Inc. |
Production of therapeutic proteins
|
TW202335693A
(zh)
|
2021-11-29 |
2023-09-16 |
美商安進公司 |
活塞桿移除力方法及設備
|
CA3236413A1
(en)
|
2021-12-03 |
2023-06-08 |
Amgen Inc. |
Stopper placement in a syringe
|
WO2023172592A1
(en)
|
2022-03-11 |
2023-09-14 |
Amgen Inc. |
Adjustable depth autoinjector
|
WO2023196111A1
(en)
|
2022-04-06 |
2023-10-12 |
Amgen Inc. |
Packaging for drug delivery device
|
WO2024028448A1
(en)
|
2022-08-04 |
2024-02-08 |
Calypso Biotech Sa |
Il-15 inhibitors useful for the treatment of atopic dermatitis
|
WO2024040020A1
(en)
|
2022-08-15 |
2024-02-22 |
Absci Corporation |
Quantitative affinity activity specific cell enrichment
|
WO2024039575A1
(en)
|
2022-08-18 |
2024-02-22 |
Amgen Inc. |
Needle shield for syringe
|
WO2024039707A1
(en)
|
2022-08-18 |
2024-02-22 |
Amgen Inc. |
Needle shield assembly for a syringe
|
WO2024049793A1
(en)
|
2022-08-30 |
2024-03-07 |
Amgen Inc. |
System and method of limiting subvisible particles in a syringe
|
CN117209605B
(zh)
*
|
2023-11-09 |
2024-01-30 |
北京百普赛斯生物科技股份有限公司 |
特异性结合il-15的抗体及其应用
|